首页> 外文期刊>The aging male: the official journal of the International Society for the Study of the Aging Male >Central hypogonadism due to a giant, 'silent' FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG)
【24h】

Central hypogonadism due to a giant, 'silent' FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG)

机译:由于巨型,“沉默”fsh分泌,非典型垂体腺瘤:腺瘤解剖和短期Leydig细胞刺激通过培黄激素和人绒毛膜促性腺激素(HCG)的影响

获取原文
获取原文并翻译 | 示例
           

摘要

We present a case report of an atypical giant pituitary adenoma secreting follicle-stimulating hormone (FSH). A 55-year-old patient presented for erectile dysfunction, loss of libido and fatigue. The biochemical evaluation showed very high FSH serum levels in the presence of central hypogonadism. Neither testicular enlargement nor increased sperm count was observed, thus a secretion of FSH with reduced biological activity was supposed. The histological examination after neuro-surgery showed an atypical pituitary adenoma with FSH-positive cells. Hypogonadism persisted and semen analyses impaired until azoospermia in conjunction with the reduction in FSH levels suggesting that, at least in part, this gonadotropin should be biologically active. Thus, we hypothesized a concomitant primary testicular insufficiency. The patient underwent short-term treatment trials with low doses of either recombinant luteinizing hormone (LH) or human chorionic gonadotropin (hCG) in three consecutive treatment schemes, showing an equal efficacy in stimulating testosterone (T) increase. This is the first case of atypical, giant FSH-secreting pituitary adenoma with high FSH serum levels without signs of testicular hyperstimulation, in presence of hypogonadism with plausible combined primary and secondary etiology. Hypophysectomized patients may represent a good model to assess both pharmacodynamics and effective dose of LH and hCG in the male.
机译:我们展示了一个非典型垂体腺瘤分泌卵泡刺激激素(FSH)的案例报告。一名55岁的患者展示了勃起功能障碍,失去性欲和疲劳。生物化学评估在中央性腺减去病症存在下表现出非常高的FSH血清水平。观察到睾丸增大和精子数量没有增加,因此假设具有降低的生物活性的FSH分泌。神经手术后的组织学检查显示出具有FSH阳性细胞的非典型垂体腺瘤。后一种后性持续和精液分析损害,直至血吸虫患者结合减少FSH水平,表明,至少部分地,这种促性腺激素应该是生物学活性的。因此,我们假设伴随的原发性睾丸功能不全。患者在三个连续的处理方案中接受了具有低剂量的重组叶氏浆化激素(LH)或人绒毛膜促性腺激素(HCG)的短期治疗试验,显示出刺激睾酮(T)增加的相等效果。这是第一种非典型巨型型垂体腺瘤的垂体腺瘤,具有高FSH血清水平而不具有睾丸过度刺激的迹象,存在于性腺组合的初级和中学生学的后性腺。衰弱的患者可以代表一个良好的模型,以评估男性的药效学和有效剂量的LH和HCG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号